0.4529

22.74% 0.0839

Pre-market: .43 -0.0229 -5.06%

Prophase Labs Inc (PRPH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Prophase Labs Inc stock is traded at $0.4529, with a volume of 1.50M. It is up +22.74% in the last 24 hours and up +61.46% over the past month. ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Previous Close:

$0.369

Open:

$0.3676

24h Volume:

1.50M

Relative Volume:

0.17

Market Cap:

$10.81M

Revenue:

$62.71M

Net Income/Loss:

$-10.48M

P/E Ratio:

-0.7189

EPS:

-0.63

Net Cash Flow:

$-13.77M

1W Performance:

+8.48%

1M Performance:

+61.46%

6M Performance:

-82.51%

1Y Performance:

-90.56%

1-Day Range:

$0.345

$0.4599

1-Week Range:

$0.345

$0.4599

52-Week Range:

$0.2179

$7.48

Prophase Labs Inc Stock (PRPH) Company Profile

Name

Prophase Labs Inc

Sector

Healthcare (1172)

Industry

Diagnostics & Research (61)

Phone

(215) 345-0919

Address

711 STEWART AVE, SUITE 200, NEW YORK, PA

Employee

113

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PRPH's Discussions on Twitter

Compare PRPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPH Prophase Labs Inc	0.4529	10.81M	62.71M	-10.48M	-13.77M	-0.63
TMO Thermo Fisher Scientific Inc	512.65	193.40B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	204.96	146.49B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	119.85	34.19B	6.53B	1.26B	1.31B	4.35
IDXX Idexx Laboratories Inc	412.40	33.54B	3.90B	887.87M	798.08M	10.67
IQV Iqvia Holdings Inc	185.42	32.69B	15.41B	1.37B	2.11B	7.50

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-21	Initiated	H.C. Wainwright	Buy
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy

Prophase Labs Inc Stock (PRPH) Latest News

Mar 07, 2025

ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq

Mar 07, 2025

ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire

Mar 07, 2025

Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan

Mar 07, 2025

Mar 06, 2025

ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World

Mar 06, 2025

Mar 05, 2025

Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance

Mar 05, 2025

Feb 27, 2025

ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News

Feb 26, 2025

Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex

Feb 26, 2025

Feb 25, 2025

ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire

Feb 25, 2025

ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq

Feb 25, 2025

ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks

Feb 25, 2025

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times

Feb 25, 2025

Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan

Feb 25, 2025

ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World

Feb 25, 2025

Feb 21, 2025

ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks

Feb 21, 2025

Feb 20, 2025

ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire

Feb 20, 2025

ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq

Feb 20, 2025

Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan

Feb 20, 2025

Feb 19, 2025

ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN

Feb 19, 2025

ProPhase Labs hires Stuart Hollenshead as COO - TipRanks

Feb 19, 2025

Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria

Feb 18, 2025

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire

Feb 18, 2025

ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com

Feb 18, 2025

ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha

Feb 18, 2025

ProPhase Labs appoints Stu Hollenshead as COO - Investing.com

Feb 18, 2025

Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan

Feb 18, 2025

Feb 17, 2025

ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa

Feb 13, 2025

ProPhase Labs appoints new COO amid executive changes - MSN

Feb 13, 2025

Feb 11, 2025

StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World

Feb 11, 2025

Feb 08, 2025

Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel

Feb 08, 2025

Feb 04, 2025